Be part of the knowledge.™

Neurology and Neurosurgery

2541

LikeLikedUnlike

286-300 of 778

MS in Children: Exploring Biomarker Research Advancements
NeuroFrontiers
MS in Children: Exploring Biomarker Research Advancements
- Ahmed Abdelhak, MD
  Peer
New Consensus for Smoldering Disease in MS
NeuroFrontiers
New Consensus for Smoldering Disease in MS
Discussing Disparities in MS Care for Underrepresented Populations
NeuroFrontiers
Discussing Disparities in MS Care for Underrepresented Populations
- Charles Turck, PharmD, BCPS, BCCCP
  Peer
- Tirisham V. Gyang, MD
  Peer
- Gopika Govindan Kutty, MD
  Peer
An Overview of MS Biomarkers
NeuroFrontiers
An Overview of MS Biomarkers
Discussing the Latest in MS Treatment and Disease-Modifying Therapies
NeuroFrontiers
Discussing the Latest in MS Treatment and Disease-Modifying Therapies
- Charles Turck, PharmD, BCPS, BCCCP
  Peer
- Jay Avasarala, MD, PhD
  Peer
Highlights from the 2023 Psych Congress
NeuroFrontiers
Highlights from the 2023 Psych Congress
- Mary Katherine Cheeley, PharmD, BCPS, CLS, FNLA
  Peer
- Craig Chepke, MD, FAPA
  Peer
advertisement
A New Hope for Patients with MS – The First FDA-Approved Biosimilar
NeuroFrontiers
A New Hope for Patients with MS – The First FDA-Approved Biosimilar
Diagnosing Suspected MS: A Review of the Updated Guidelines
NeuroFrontiers
Diagnosing Suspected MS: A Review of the Updated Guidelines
- Andrew Wilner, MD, FACP, FAAN
  Peer
- Eoin Flanagan, MB, BCh
  Peer
The Hidden Struggles of Tardive Dyskinesia: Improving Patient Care
NeuroFrontiers
The Hidden Struggles of Tardive Dyskinesia: Improving Patient Care
Locked Up in My Own Mind: Challenges in the Criminal Justice System
Psych Congress Action Center
Locked Up in My Own Mind: Challenges in the Criminal Justice System
Clarity for Schizophrenia: The Latest in Drug Treatment
Psych Congress Action Center
Clarity for Schizophrenia: The Latest in Drug Treatment
Why Humans Developed Memory
What Your Patients Are Talking About
Why Humans Developed Memory
- Brian P. McDonough, MD, FAAFP
  Peer
advertisement
New Drug Approved for PPD: Solving an Unmet Need
NeuroFrontiers
New Drug Approved for PPD: Solving an Unmet Need
Studying the Safety of Discontinuing DMTs in MS Older Adults
NeuroFrontiers
Studying the Safety of Discontinuing DMTs in MS Older Adults
- Andrew Wilner, MD, FACP, FAAN
  Peer
- John R. Corboy, MD
  Peer
Uncovering Disease Progression in Multiple Sclerosis
NeuroFrontiers
Uncovering Disease Progression in Multiple Sclerosis
- Sergio Baranzini, PhD
  Peer

Program Chapters

Segment Chapters

Playlist:

Recommended